Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA254351
National Institute of Health
Grant: R01CA260857
National Institute of Health
Grant: R01CA247441
National Institute of Health
Grant: R03CA256764
National Institute of Health
Grant: P01CA261669
United States Department of Defense
Grant: W81XWH-21-1-0738
United States Department of Defense
Grant: W81XWH-19-1-0284
German Cancer Aid
Grant: Mildred-Scheel Postdoctoral Fellowship
NCI NIH HHS
Grant: R01 CA260872
National Institutes of Health
Grant: 1P01CA261669-01
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
National Institutes of Health
Grant: 1R01CA247441-01A1
Vascularized tumor explants for drug testing
National Institutes of Health
Grant: 5R01CA260872-03
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
National Institutes of Health
Grant: 5R01CA260857-03
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
National Institutes of Health
Grant: 5R03CA256764-02
Radiation and CSPG4-specifc CAR T cell based combinatorial therapy for the in vivo treatment of TNBC
FWCI
0.37
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals